Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 474 participants.

Also called NCT04481919

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 474 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04481919
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04481919. Randomized; quadruple masking; primary purpose treatment. Start 2022-05-01 (actual); primary completion 2025-11-22 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)
Acronym
ESCALATE
Condition
Heart Failure
Condition
Acute Heart Failure
Intervention (Drug)
Protocolized diuretic therapy
Lead sponsor
Vanderbilt University Medical Center (class: other)

Record details

Record id
cardio:ct-nct04481919
Content hash
52d05271d7e6ede16721d195e2e202025c5f09073dc4defab51a78713465ae45